These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 25253389)

  • 1. Poised epigenetic states and acquired drug resistance in cancer.
    Brown R; Curry E; Magnani L; Wilhelm-Benartzi CS; Borley J
    Nat Rev Cancer; 2014 Nov; 14(11):747-53. PubMed ID: 25253389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
    Wilting RH; Dannenberg JH
    Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy?
    Perez-Plasencia C; Duenas-Gonzalez A
    Mol Cancer; 2006 Jul; 5():27. PubMed ID: 16831224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Epigenetic Therapy to Overcome Chemotherapy Resistance.
    Strauss J; Figg WD
    Anticancer Res; 2016 Jan; 36(1):1-4. PubMed ID: 26722021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Alterations and Mechanisms That Drive Resistance to Targeted Cancer Therapies.
    Wajapeyee N; Gupta R
    Cancer Res; 2021 Nov; 81(22):5589-5595. PubMed ID: 34531319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of anti-tumour drug resistance with epigenetic regulation.
    Hayashi T; Konishi I
    Br J Cancer; 2021 Feb; 124(4):681-682. PubMed ID: 33268818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic reprogramming and potential application of epigenetic-modifying drugs in acquired chemotherapeutic resistance.
    Ponnusamy L; Mahalingaiah PKS; Singh KP
    Adv Clin Chem; 2020; 94():219-259. PubMed ID: 31952572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral Heterogeneity: From Diversity Comes Resistance.
    Pribluda A; de la Cruz CC; Jackson EL
    Clin Cancer Res; 2015 Jul; 21(13):2916-23. PubMed ID: 25838394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and Epigenetic Modulation of Drug Resistance in Cancer: Challenges and Opportunities.
    Shah K; Rawal RM
    Curr Drug Metab; 2019; 20(14):1114-1131. PubMed ID: 31902353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance.
    Zhou Y; Sun W; Qin Z; Guo S; Kang Y; Zeng S; Yu L
    Biochem Pharmacol; 2021 Jul; 189():114228. PubMed ID: 32976832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic Regulators.
    Rauscher S; Greil R; Geisberger R
    Curr Cancer Drug Targets; 2021; 21(4):353-359. PubMed ID: 33423645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of acquired resistance to targeted cancer therapies.
    Lackner MR; Wilson TR; Settleman J
    Future Oncol; 2012 Aug; 8(8):999-1014. PubMed ID: 22894672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PROTACs: Promising Approaches for Epigenetic Strategies to Overcome Drug Resistance.
    Giardina SF; Valdambrini E; Warren JD; Barany F
    Curr Cancer Drug Targets; 2021; 21(4):306-325. PubMed ID: 33535953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG-island methylation and epigenetic control of resistance to chemotherapy.
    Teodoridis JM; Strathdee G; Plumb JA; Brown R
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):916-7. PubMed ID: 15506923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy.
    Lu Y; Chan YT; Tan HY; Li S; Wang N; Feng Y
    Mol Cancer; 2020 Apr; 19(1):79. PubMed ID: 32340605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-coding RNAs and Drug Resistance.
    Pan JJ; Xie XJ; Li X; Chen W
    Asian Pac J Cancer Prev; 2015; 16(18):8067-73. PubMed ID: 26745040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.
    Easwaran H; Tsai HC; Baylin SB
    Mol Cell; 2014 Jun; 54(5):716-27. PubMed ID: 24905005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of epigenome in tumorigenesis and drug resistance.
    Hu Q; Baeg GH
    Food Chem Toxicol; 2017 Nov; 109(Pt 1):663-668. PubMed ID: 28709969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours.
    Selli C; Turnbull AK; Pearce DA; Li A; Fernando A; Wills J; Renshaw L; Thomas JS; Dixon JM; Sims AH
    Breast Cancer Res; 2019 Jan; 21(1):2. PubMed ID: 30616553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer's epigenetic drugs: where are they in the cancer medicines?
    Ghasemi S
    Pharmacogenomics J; 2020 Jun; 20(3):367-379. PubMed ID: 31819161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.